These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6283412

  • 1. Cardiovascular effects of intracerebroventricular injection of dopamine after selective MAO inhibition in rats.
    Pazos A, Mediavilla A, Flórez J.
    Neuropharmacology; 1982 Apr; 21(4):317-22. PubMed ID: 6283412
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 3. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L, Bunag RD.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.
    Cohen RM, Campbell IC, Yamaguchi I, Pickar D, Kopin IJ, Murphy DL.
    Eur J Pharmacol; 1982 May 07; 80(1):155-60. PubMed ID: 6284529
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.
    Finberg JP, Gross A, Bar-Am O, Friedman R, Loboda Y, Youdim MB.
    Br J Pharmacol; 2006 Nov 07; 149(6):647-56. PubMed ID: 17016505
    [Abstract] [Full Text] [Related]

  • 6. Effects of monoamine oxidase inhibitors and dopamine agonists on the behavior of mammal- and frog-eating snakes.
    Temple JG, Barthalmus GT.
    Physiol Behav; 1994 May 07; 55(5):927-33. PubMed ID: 7912837
    [Abstract] [Full Text] [Related]

  • 7. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ, Harland D.
    Br J Pharmacol; 1986 Feb 07; 87(2):361-70. PubMed ID: 3006858
    [Abstract] [Full Text] [Related]

  • 8. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 07; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 9. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Aug 07; 37(2):527-30. PubMed ID: 6790675
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR, Palfreyman MG, Robin M, Zreika M.
    Br J Pharmacol; 1986 Jan 07; 87(1):257-64. PubMed ID: 3082400
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.
    Bar-Am O, Gross A, Friedman R, Finberg JP.
    Eur J Pharmacol; 2012 May 15; 683(1-3):226-30. PubMed ID: 22465184
    [Abstract] [Full Text] [Related]

  • 12. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF, McCauley RB, Fontana DJ, McIntyre IM, Commissaris RL.
    J Neural Transm; 1986 May 15; 66(3-4):271-80. PubMed ID: 3097249
    [Abstract] [Full Text] [Related]

  • 13. Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.
    Mercuri NB, Scarponi M, Bonci A, Siniscalchi A, Bernardi G.
    J Neurosci; 1997 Apr 01; 17(7):2267-72. PubMed ID: 9065488
    [Abstract] [Full Text] [Related]

  • 14. Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
    Arnerić SP, Long JP.
    J Pharm Pharmacol; 1984 May 01; 36(5):318-21. PubMed ID: 6145768
    [Abstract] [Full Text] [Related]

  • 15. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G, Gabilondo AM, Miralles A, Escriba PV, García-Sevilla JA.
    Br J Pharmacol; 1993 Mar 01; 108(3):597-603. PubMed ID: 8385528
    [Abstract] [Full Text] [Related]

  • 16. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH.
    J Endocrinol; 1994 Nov 01; 143(2):303-8. PubMed ID: 7829993
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep 01; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.